Invariant NKT cells: regulation and function during viral infection.
Natural killer T cells (NKT cells) represent a subset of T lymphocytes that express natural killer (NK) cell surface markers. A subset of NKT cells, termed invariant NKT cells (iNKT), express a highly restricted T cell receptor (TCR) and respond to CD1d-restricted lipid ligands. iNKT cells are now appreciated to play an important role in linking innate and adaptive immune responses and have been implicated in infectious disease, allergy, asthma, autoimmunity, and tumor surveillance. Advances in iNKT identification and purification have allowed for the detailed study of iNKT activity in both humans and mice during a variety of chronic and acute infections. Comparison of iNKT function between non-pathogenic simian immunodeficiency virus (SIV) infection models and chronic HIV-infected patients implies a role for iNKT activity in controlling immune activation. In vitro studies of influenza infection have revealed novel effector functions of iNKT cells including IL-22 production and modulation of myeloid-derived suppressor cells, but ex vivo characterization of human iNKT cells during influenza infection are lacking. Similarly, as recent evidence suggests iNKT involvement in dengue virus pathogenesis, iNKT cells may modulate responses to a number of emerging pathogens. This Review will summarize current knowledge of iNKT involvement in responses to viral infections in both human and mouse models and will identify critical gaps in knowledge and opportunities for future study. We will also highlight recent efforts to harness iNKT ligands as vaccine adjuvants capable of improving vaccination-induced cellular immune responses.
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Jennifer A
JA
Juno
Yoav
Y
Keynan
Keith R
KR
Fowke
D000208:Acute Disease; D000818:Animals; D055610:Antigens, CD1d / Q000276:immunology; D002908:Chronic Disease; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007378:Interleukins / Q000276:immunology; D008055:Lipids / Q000276:immunology; D051379:Mice; D055611:Natural Killer T-Cells / Q000276:immunology*; D014611:Vaccination; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use; D014777:Virus Diseases / Q000276:immunology* / Q000517:prevention & control; D000097043:Interleukin-22
D055610:Antigens, CD1d; D007378:Interleukins; D008055:Lipids; D014765:Viral Vaccines; D000097043:Interleukin-22; C526877:CD1D protein, human